M S Ramaiah Narayana Heart Centre commemorates World Heart Day by giving a new lease of life to a 40 year old heart patient

IMT News Desk
IMT News Desk
· 2 min read

Bengaluru, September 29, 2019:  M S Ramaiah Narayana Heart Centre– a unit managed by Narayana Health, today celebrated World Heart Day by successfully performing a heart transplant surgery.

Hailing from Mysore, the recipient was suffering from Ischemic dilated cardiomyopathy. He was under medical management at M S Ramaiah Narayana Heart Centre. After a thorough evaluation by the team of cardiologists and cardiac surgeons, the patient was advised a heart transplant. He had registered with Jeevasarthakate (ZCCK) 4 months ago.

The donor was a 26 year old, who had met with an accident. He was declared brain dead yesterday night at Manipal Hospital, Old Airport Road, Benagluru and his family consented for organ donation. The heart was transported from Manipal Hospital, Old Airport Road, Bengaluru to M S Ramaiah Narayana Heart Centre, BEML Road, Benagluru at 2.00 am.

The heart retrieval and transplant was performed by Dr. Ravi Shankar Shetty, Senior Consultant Cardiothoracic & Heart Transplant Surgeon, M S Ramaiah Narayana Heart Centre, Dr. Nagamalesh. U.M, Senior Consultant Heart Failure & Transplant, M S Ramaiah Narayana Heart Centre, Dr. Varun Shetty, Senior Consultant Cardiac Surgeon, Narayana Health City, Dr. Prashanth Ramamurthy, Consultant Cardiac Anaesthetist, M S Ramaiah Narayana Heart Centre and  Dr. Guru Police Patil Anaesthetist, M S Ramaiah Narayana Heart Centre.

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk